Astaxanthin 4 mg with Phospholipids
Single ingredient · 30 servings · $12.00 · 4.6 stars from 589 reviews
Unproven for New cell production
Nothing we've read
- Evidence Unproven
- Dose 1 of 1 at a studied dose
- Safety Read the label's warnings
- Fillers None of concern
What's in it
A clean, single-ingredient formula, but we don't yet have a clinical dose range or a Daily Value to check Astaxanthin Phospholipid Proprietary Blend against.
Supplement Facts
Serving Size: 1 Softgel(s)
30 per container
- Astaxanthin Phospholipid Proprietary Blend 84 mg †
- Phospholipids — †
- Astaxanthin as Haematococcus pluvialis Algae Extract — †
- Astaxanthin 4 mg †
† Daily Value not established
Other ingredients: Sunflower Oil, Gelatin, Glycerin, Extra Virgin Olive Oil, Water, Purified.
Directions: Take one (1) softgel once or twice daily, or as recommended by a healthcare practitioner.
Doses against the trials
-

Astaxanthin
At the studied dose
4 mg a day studies used 2–28 mg · 73 studies
1 more on the label with no studied dose or Daily Value to check against.
What it's sold for
-
New cell production
Unproven
-
Antioxidant support
Worth trying
-
Heart health
Worth trying
-
Skin health
Worth trying
-
Eye health
Unproven
Better everyday vision: unclear if it helps
-
Joint health
Unproven
-
Brain health
Unproven
Worth knowing
The label's warnings
Read the entire label and follow the directions carefully prior to use.
When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.
To report a serious adverse event or obtain product information, contact 1-866-280-2852.
The other ingredients
Clean formula. The inactive ingredients are standard capsule components.
- Sunflower Oil
- Gelatin: capsule shell; neutral unless ethical concern
- Glycerin: capsule plasticizer; benign
- Extra Virgin Olive Oil
- Water, Purified
Free from
Gluten Free. Gluten Free Non GMO Le Certified
Life Extension
90 out of 100
Brand audit score
Life Extension's quality posture is strong on testing and transparency, but a 2017 FDA warning letter limits a full trust endorsement.